Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Chronic Disease Research Group Study Shows Daily Home Hemodialysis Therapy with the NxStage® System Oneâ„¢ is Associated with Lower Risk of Mortality and Higher Survival Estima…

April 28, 2011 By Bio-Medicine.Org

LAWRENCE, Mass., April 28, 2011 /PRNewswire/ — NxStage Medical,
Inc. (Nasdaq:
NXTM
), a leading manufacturer of innovative dialysis products,
today commented on study results presented by the Chronic Disease
Research Group (CDRG) showing daily home hemodialysis with the
NxStage System One is associated with reduced mortality and higher
survival estimates for patients when compared with conventional
thrice-weekly therapy. The retrospective cohort study examines the
mortality and three-year survival rates of 1,873 daily home
hemodialysis (DHHD) patients using the NxStage System One between
2005 and 2007, to a matched cohort of 9,365 in-center hemodialysis
patients from the United States Renal Data System (USRDS) database.
CDRG is a nonprofit division of the Minneapolis Medical Research
Foundation committed to investigating chronic illness to improve
public health, including leveraging USRDS data to conduct
studies.

The study, “Relative Mortality in Daily Home and Matched,
Thrice-Weekly In-Center Hemodialysis Patients,” conducted by CDRG
was presented at this week’s National Kidney Foundation 2011 Spring
Clinical Meeting in Las Vegas.

“This is the first study of its kind to carefully match the
daily home hemodialysis patient population with comparable
in-center dialysis patients based on variables such as comorbidity
 and severity of disease, determining the impact on
mortality,” said Dr. Allan Collins, professor of medicine,
University of Minnesota, and director, Chronic Disease Research
Group. “Results show a reduction in mortality for daily home
hemodialysis patients consistent with recently published National
Institutes of Health data on frequent home dialysis versus
in-center therapy, though additional studies are needed to assess
patient hospitalization risk and type of hospitalization.”

Researchers compared daily home hemodialysis patient data with
the

‘/>”/>

SOURCE

Related Articles Read More >

TE Connectivity opens global medical device prototyping center in Ireland
Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech